Author

Lisanne C.A. Smidt

Observed names: L. Smidt, Lisanne C A Smidt, Lisanne C. A. Smidt, Lisanne Smidt, Lisanne C.A. Smidt, Smidt, Lisanne C. A.

Institutions: Leiden University, Leiden University Medical Center, Centre for Human Drug Research

Observed institutions: Leiden University, Leiden University Medical Center, University Medical Center Utrecht, Centre for Human Drug Research, Meander Medisch Centrum, Wilhelmina Children's Hospital

ORCID: 0000-0003-2663-3773

Observed ORCID: 0000-0003-2663-3773

OpenAlex ID: A5085234038

Predictors of Outcomes in Hypoxic-Ischemic Encephalopathy following Hypothermia: A Meta-Analysis

2020 · Sabine Ouwehand, Lisanne C.A. Smidt, et al. · Neonatology · 107

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review

2018 · Anouk van Westrhenen, Lisanne C. A. Smidt, et al. · British Journal of Haematology · 54

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

2023 · Johan L van der Plas, Vincent P Kuiper, et al. · The Lancet Infectious Diseases · 22

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience

2021 · K. Zwart, S. Velthuis, et al. · Netherlands Heart Journal · 6

First‐In‐Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT‐02 Freebase, a CNS‐Penetrant NLRP3 Inhibitor

2026 · Lisanne C. A. Smidt, Matthijs Moerland, et al. · Clinical and Translational Science · 2

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease

2021 · Lisanne C. A. Smidt, Frank L. J. Visseren, et al. · Cardiovascular Diabetology · 2

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

2025 · Juliette A. van den Noort, Marella C. E. van Ruissen, et al. · British Journal of Clinical Pharmacology · 1

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Chemoprophylactic Activity of M5717 Against Plasmodium Falciparum in a Controlled Human Malaria Infection

2022 · Johan L. van der Plas, Vincent P. Kuiper, et al. · SSRN Electronic Journal · 1

Respiratory virus background immunity assessment

2024 · Ingrid de Visser, Lisanne Smidt · http://isrctn.com/

Works count: 11

Citation count: 195

H-index: 4

I10-index: 3